Future prospective studies should incorporate comprehensive ophthalmic assessment, including detailed history, fundus examination, and OCT imaging, to confirm NAION only after excluding other potential causes of optic neuropathy such as giant cell arteritis or optic neuritis
Himanshu Morya, MBBS, Medical Educator and College Faculty About the Author Iraphan Khan, BSN, D.Pharm, CMLT, Founder of RealMedVision | Public Health Researcher Iraphan Khan is the founder of RealMedVision, where he creates clear, evidence-based health content for patients and families using trusted medical sources like the WHO, ADA, and NHS.
Lekarz podczas konsultacji online moe pomc oceni pilno problemu i wskaza waciw ciek postpowania, ale nie zastpi badania fizykalnego, bada obrazowych czy leczenia w trybie nagym, jeli s potrzebne
Nearly one-third (31.7%) of patients discontinued GLP-1 therapy within 180 days
In sum, GLP1 RAs are positioned as one of the pharmacotherapeutic options that can contribute to addressing the high unmet medical need characterising several prevalent agingrelated diseases, potentially helping more people enjoy a prolonged healthy lifespan
Those patients who have a history of pancreatitis, gallbladder disease, or kidney problems may not be eligible for semaglutide GLP-1 injections
